# Redhill Biopharma Ltd.

Canonical: https://abierto.us/vendors/redhill-biopharma-ltd-nkn1xz8d6kg5

- UEI: NKN1XZ8D6KG5
- CAGE: 2967A
- Location: TEL-AVIV, ISR
- Awards in window: 1 (2 transactions), $733,382 obligated, September 27, 2024 to September 3, 2025

## Awarding agencies

- Office of Assistant Secretary for Preparedness and Response: 1 awards, $733,382

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $733,382

## Competition

- Full and Open Competition: 1 awards

## Largest awards

- 75A50124C00059 (definitive contract): $733,382, Barda - Aspr / Daappo / Barda DCMA. Redhill Biopharma Ltd-Opaganib as Host-Directed Therapeutic for Ebola Virus Disease. https://www.usaspending.gov/award/CONT_AWD_75A50124C00059_7505_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/redhill-biopharma-ltd-nkn1xz8d6kg5.